FDA Mandate Episode #3: Last Chance for Public Comment

FDA Mandate Episode #3: Last Chance for Public Comment

Curious about the FDA’s mandate for diversity in clinical trials? Now’s the opportunity to make your voice heard as a health care provider. Watch our esteemed clinical trial experts discuss the mandate and how you can comment on it before September 26th, 2024.

Our live panelists include Tania Small (Head of Medical Affairs, Bristol Myers Squibb), Ivory Allison (National Senior Director
Community Impact, American Liver Foundation), Ruemu E. Birhiray, MD (Medical Oncologist, Hematology Oncology Of Indiana), and Leslie Henderson-Williams (Director, Global Diversity & Inclusion for Clinical Trials, Patient and Site Centric Solutions, IQVIA). BlackDoctor.org’s executive editor, Jade Curtis, will be moderating.

Tune in tonight at 5pm EST on Facebook Live or LinkedIn to have all of your clinical trial questions answered and make an informed comment on the action plans that affect the Black community.

Read More About Public Health